Improving Biomarker Driven Precision Therapy in NSCLC: Less Common, More Complex: Multidisciplinary Discussion of Safety and Efficacy of TKIs for Rare Mutations in NSCLC September 29, 2021
Improving Biomarker Driven Precision Therapy in NSCLC: The Importance of an Integrated Multidisciplinary Approach Part 2 - Less Common, More Complex: Multidisciplinary Discussion of Safety and Efficacy of TKIs for Rare Mutations in NSCLC
Category
  • Hematology/Oncology
Format
  • Online live
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Improving Biomarker Driven Precision Therapy in NSCLC: Uncovering ALK in Clinical Practice: Physician, Pharmacist, and Patient Perspectives (2022)
Improving Biomarker Driven Precision Therapy in NSCLC:  Uncovering ALK in Clinical Practice: Physician, Pharmacist, and Patient Perspectives
Category
  • Hematology/Oncology
Format
  • Online live
Credits
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
Improving Biomarker Driven Precision Therapy in NSCLC: Less Common, More Complex: Multidisciplinary Discussion of Safety and Efficacy of TKIs for Rare Mutations in NSCLC October 4, 2022
Register directly through Zoom here - https://bostonu.zoom.us/webinar/register/WN_s2cI-AAEQJetC3wa-RjBvgBiomarker based testing and precision medicine based approaches have become a standard to guide treatme
Category
  • Hematology/Oncology
Format
  • Online live
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation